![美国生物医学学会/[P03]人载脂蛋白AI（Apo AI）/7](https://www.ebiomall.cn/images/academybiomed/P03_AI_300x300.png)
美国生物医学学会/[P03]人载脂蛋白AI（Apo AI）/7
商品编号：
7
品牌：
academybiomed
市场价：
¥0.00
美元价：
0.00
产品分类：
分光光度计
公司分类：
Spectrophotometer
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
| Concentration: | 1 mg / ml, determined by the Lowry method |
| Source: | From fresh human plasma that has tested negative for Hepatitis C, HIV-I and HIV-II antibodies as well as Hepatitis surface antigens. |
| Purification: | After series ultracentrifugations, High Density Lipoprotein (HDL) is isolated from human plasma. Apo AI is purified from delipidated HDL, followed by gel-filtration. |
| Purity: | ≥ 98% by SDS-PAGE |
| Buffer: | 20 mM Tris-HCl, 140 mM NaCl, 0.02% NaN3, 0.5 mM EDTA, pH 7.4. |
| Storage: | -20°C for long-term storage, 4°C for short- term storage. Aliquot to avoid repeated freezing and thawing. |
Importance
Apo AI comprises approximately 70% of the protein moiety in HDL. It is a single polypeptide chain consisting of 243 amino acid residues without disulfide bound and with glutamic acid as the C-terminal residue and aspartic acid as the N-terminal residue. The molecular weight is reported to be 28 kDa (Brewer et al., 1978).
The roles of Apo AI in HDL function include reverse cholesterol transportation, lipid cholesterol binding, lecithin-cholesterol acyl transferase (LCAT) activation, and receptor binding, which is responsible for cholesterol esterification in plasma. Besides participate in cholesterol metabolism, Apo AI and HDL also suppress neutrophil activation, inhibit bacterial endotoxin, induce trypanosomal lysis, and other physiological activities. (Brouillette et al., 2001)
Apo AI levels may be inversely related to the risk of coronary disease. In previous research, Apo AI may affect diet-induced inflammation by either directly or indirectly altering lipid rafts. (Cheng et al., 2012)
Brewer, H. B., T. Fairwell, A. LaRue, R. Ronan, A. Houser, and T. J. Bronzert. “The amino acid sequence of human Apoa-I, an apolipoprotein isolated from high density lipoproteins.” Biochemical and Biophysical Research Communications 80.3 (1978): 623-30.
Brouillette, Christie G., G.m. Anantharamaiah, Jeffrey A. Engler, and David W. Borhani. "Structural Models of Human Apolipoprotein A-I: A Critical Analysis and Review." Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2001): 4-46.
Cheng, Andrew M., Priya Handa, Sanshiro Tateya, Jay Schwartz, Chongren Tang, Poulami Mitra, John F. Oram, Alan Chait, and Francis Kim. "Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts." PLoS ONE 7.3 (2012): e33917.
Citations
| [P03][P04] | 2020 | Stamatikos, Alexis; Knight, Ethan; Vojtech, Lucia; Bi, Lianxiang; Wacker, Bradley K.; Tang, Chongren; Dichek, David A. (2020): Exosome-Mediated Transfer of Anti-miR-33a-5p from Transduced Endothelial Cells Enhances Macrophage and Vascular Smooth Muscle Cell Cholesterol Efflux. Human Gene Therapy 31 (3-4), pp. 219–232. DOI: 10.1089/hum.2019.245. |
| [P03][P04] | 2019 | Hsu, Yun-Hsun; Toh, Jia-Jia; Chang, Chiz-Tzung; Liu, Mine-Yine (2019): Investigating apolipoproteins of human high-density lipoprotein by cyclodextrin-micellar electrokinetic chromatography. Journal of Chromatography. A 1593, pp. 164–173. DOI: 10.1016/j.chroma.2019.01.073. |
| [P03][P04] | 2018 | Woller, Sarah A.; Choi, Soo-Ho; An, Eun Jung; Low, Hann; Schneider, Dina A.; Ramachandran, Roshni et al. (2018): Inhibition of Neuroinflammation by AIBP: Spinal Effects upon Facilitated Pain States. In Cell reports 23 (9), pp. 2667–2677. DOI: 10.1016/j.celrep.2018.04.110. |
| [P03][P04] | 2016 | Han, Chang Yeop; Tang, Chongren; Guevara, Myriam E.; Wei, Hao; Wietecha, Tomasz; Shao, Baohai et al. (2016): Serum amyloid A impairs the antiinflammatory properties of HDL. In The Journal of clinical investigation 126 (1), pp. 266–281. DOI: 10.1172/JCI83475. |
| [P03][P04] | 2016 | Yassine, Hussein N.; Feng, Qingru; Chiang, Jiarong; Petrosspour, Larissa M.; Fonteh, Alfred N.; Chui, Helena C.; Harrington, Michael G. (2016): ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer"s Disease. In Journal of the American Heart Association 5 (2). DOI: 10.1161/JAHA.115.002886. |
| [P03][P04] | 2015 | Zhang, Hongming; Li, Xiaoyan; Qian, Zongjie (2015): Regulation of macrophage cholesterol efflux and liver X receptor α activation by nicotine. In International journal of clinical and experimental medicine 8 (9), pp. 16374–16378. |
| [P03][P04] | 2014 | Braesch-Andersen, Sten; Beckman, Lena; Paulie, Staffan; Kumagai-Braesch, Makiko (2014): ApoD mediates binding of HDL to LDL and to growing T24 carcinoma. In PLoS ONE 9 (12), e115180. DOI: 10.1371/journal.pone.0115180. |
| [P03][P04] | 2014 | Talayero, Beatriz; Wang, Liyun; Furtado, Jeremy; Carey, Vincent J.; Bray, George A.; Sacks, Frank M. (2014): Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease. In J. Lipid Res. 55 (10), pp. 2167–2177. DOI: 10.1194/jlr.M042333. |
| [P03][P04] | 2013 | Hibert, Pierre; Prunier-Mirebeau, Delphine; Beseme, Olivia; Chwastyniak, Maggy; Tamareille, Sophie; Lamon, Delphine et al. (2013): Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning. In PLoS ONE 8 (10), e77211. DOI: 10.1371/journal.pone.0077211. |
| [P03][P04] | 2013 | Umemoto, Tomio; Han, Chang Yeop; Mitra, Poulami; Averill, Michelle M.; Tang, Chongren; Goodspeed, Leela et al. (2013): Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. In Circulation research 112 (10), pp. 1345–1354. DOI: 10.1161/CIRCRESAHA.111.300581. |
| [P03][P04] | 2012 | Cheng, Andrew M.; Handa, Priya; Tateya, Sanshiro; Schwartz, Jay; Tang, Chongren; Mitra, Poulami et al. (2012): Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts. In PLoS ONE 7 (3), e33917. DOI: 10.1371/journal.pone.0033917. |
| [P03][P04] | 2011 | Borges, Chad R.; Oran, Paul E.; Buddi, Sai; Jarvis, Jason W.; Schaab, Matthew R.; Rehder, Douglas S. et al. (2011): Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity. In Clinical chemistry 57 (5), pp. 719–728. DOI: 10.1373/clinchem.2010.156976. |
| [P03][P04] | 2011 | Wang, Yanan; Berbée, Jimmy F. P.; Stroes, Erik S.; Smit, Johannes W. A.; Havekes, Louis M.; Romijn, Johannes A.; Rensen, Patrick C. N. (2011): CETP expression reverses the reconstituted HDL-induced increase in VLDL. In J. Lipid Res. 52 (8), pp. 1533–1541. DOI: 10.1194/jlr.M016659. |
| [P03][P04] | 2009 | Hongo, Shigeki; Watanabe, Takuya; Arita, Shigeko; Kanome, Tomoko; Kageyama, Haruaki; Shioda, Seiji; Miyazaki, Akira (2009): Leptin modulates ACAT1 expression and cholesterol efflux from human macrophages. In American Journal of Physiology-Endocrinology and Metabolism 297 (2), E474-82. DOI: 10.1152/ajpendo.90369.2008. |
| [P03][P04] | 2009 | Vries-van der Weij, Jitske de; Haan, Willeke de; Hu, Lihui; Kuif, Maarten; Oei, H. Ling D. W.; van der Hoorn, José W. A. et al. (2009): Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein. In Endocrinology 150 (5), pp. 2368–2375. DOI: 10.1210/en.2008-1540. |
| [P03][P04] | 2008 | Troutt, Jason S.; Alborn, William E.; Mosior, Marian K.; Dai, Jiannong; Murphy, Anthony T.; Beyer, Thomas P. et al. (2008): An apolipoprotein A-I mimetic dose-dependently increases the formation of prebeta1 HDL in human plasma. In J. Lipid Res. 49 (3), pp. 581–587. DOI: 10.1194/jlr.M700385-JLR200. |
| [P03][P04] | 2007 | Nagalla, Srinivasa R.; Canick, Jacob A.; Jacob, Thomas; Schneider, Kimberly A.; Reddy, Ashok P.; Thomas, Archana et al. (2007): Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers. In J. Proteome Res. 6 (4), pp. 1245–1257. DOI: 10.1021/pr060539h. |
| [P03][P04] | 2006 | Yokoyama, Yuichiro; Kuramitsu, Yasuhiro; Takashima, Motonari; Iizuka, Norio; Terai, Shuji; Oka, Masaaki et al. (2006): Protein level of apolipoprotein E increased in human hepatocellular carcinoma. In International journal of oncology 28 (3), pp. 625–631. |
| [P03][P04] | 2005 | Lee, Ching Yin; Lesimple, Alain; Larsen, Asmund; Mamer, Orval; Genest, Jacques (2005): ESI-MS quantitation of increased sphingomyelin in Niemann-Pick disease type B HDL. In J. Lipid Res. 46 (6), pp. 1213–1228. DOI: 10.1194/jlr.M500011-JLR200. |
| [P03][P04] | 2003 | Lee, Ching Yin; Krimbou, Larbi; Vincent, Jérôme; Bernard, Chantal; Larramée, Pierre; Genest, Jacques; Marcil, Michel (2003): Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterol. In Human genetics 112 (5-6), pp. 552–562. DOI: 10.1007/s00439-002-0893-1. |
| [P03][P04] | 2003 | Sniderman, Allan D.; Zhang, ZuJun; Genest, Jacques; Cianflone, Katherine (2003): Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells. In J. Lipid Res. 44 (3), pp. 527–532. DOI: 10.1194/jlr.M200187-JLR200. |
| [P03][P04] | 2002 | Rong, Rong; Ramachandran, Sumathi; Penumetcha, Meera; Khan, Nadya; Parthasarathy, Sampath (2002): Dietary oxidized fatty acids may enhance intestinal apolipoprotein A-I production. In J. Lipid Res. 43 (4), pp. 557–564. |
品牌介绍
自1995年以来，Academy生物医学公司一直致力于以合理的价格向心血管和动脉粥样硬化研究领域提供高质量的抗体。我们很荣幸为科学界提供我们致力于脂蛋白，载脂蛋白领域研究的抗体和试剂。 ，以及它们的氧化改性产物。
联络我们
